<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:hpo ids='HP_0003741'>congenital muscular dystrophies</z:hpo> are a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> group of disorders in which <z:mp ids='MP_0000746'>weakness</z:mp> and dystrophic pattern on muscle biopsy are present at birth or during the first months of life </plain></SENT>
<SENT sid="1" pm="."><plain>This chapter reviews the most common forms of <z:hpo ids='HP_0003741'>congenital muscular dystrophies</z:hpo>, including laminin α-2 (merosin) deficiency, Ullrich <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo>, fukutin-related proteinopathy, <z:hpo ids='HP_0003306'>rigid spine</z:hpo> syndrome, and glycosylation disorders of α-dystroglycan </plain></SENT>
<SENT sid="2" pm="."><plain>The latter group is often associated with neuronal migration defects including <z:hpo ids='HP_0001339'>lissencephaly</z:hpo>, <z:hpo ids='HP_0001302'>pachygyria</z:hpo>, cerebellar and brainstem abnormalities, and variable ocular anomalies </plain></SENT>
<SENT sid="3" pm="."><plain>Typical clinical findings and underlying genetic defects are discussed to assist in the differential diagnosis and diagnostic work-up of patients with <z:hpo ids='HP_0003741'>congenital muscular dystrophies</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>There are still no curative treatment options for patients with <z:hpo ids='HP_0003741'>congenital muscular dystrophies</z:hpo> but regular follow-up and symptomatic care by a multidisciplinary team considering the peculiarities of each disorder are important to maintain or improve patients' quality of life </plain></SENT>
</text></document>